| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
HALO
Halozyme
|
Jun 16, 2026 | BUY |
Strong Buy
-13.7% avg upside
20 analysts
|
$95.00
38.55% Upside
|
-1.5% |
|
NTLA
Intellia Therapeutics
|
Jun 15, 2026 | BUY |
Buy
+151.9% avg upside
37 analysts
|
$25.00
59.48% Upside
|
· |
|
DMRA
Damora Therapeutics
|
Jun 11, 2026 | BUY |
Strong Buy
+28.3% avg upside
19 analysts
|
$45.00
111.94% Upside
|
· |
|
INCY
Incyte
|
Jun 10, 2026 | BUY |
Buy
+1.0% avg upside
47 analysts
|
$140.00
42.56% Upside
|
-6.1% |
|
LYEL
Lyell Immunopharma
|
Jun 09, 2026 | BUY |
Buy
+96.2% avg upside
10 analysts
|
$45.00
253.29% Upside
|
· |
|
NGNE
Neurogene
|
Jun 09, 2026 | BUY |
Buy
+55.5% avg upside
23 analysts
|
$70.00
121.92% Upside
|
· |
|
KYTX
Kyverna Therapeutics, Inc.
|
Jun 04, 2026 | BUY |
Strong Buy
+238.7% avg upside
7 analysts
|
$25.00
209.81% Upside
|
+1.1% |
|
LEGN
Legend Biotech
|
Jun 03, 2026 | BUY |
Strong Buy
+140.3% avg upside
27 analysts
|
$65.00
132.63% Upside
|
-0.3% |
|
ORKA
Oruka Therapeutics
|
Jun 03, 2026 | BUY |
Strong Buy
+61.8% avg upside
16 analysts
|
$120.00
65.96% Upside
|
+23.9% |
|
IONS
Ionis Pharmaceuticals
|
Jun 01, 2026 | BUY |
Strong Buy
+13.3% avg upside
43 analysts
|
$125.00
68.74% Upside
|
-2.8% |
|
SMMT
Summit Therapeutics
|
Jun 01, 2026 | HOLD |
Strong Buy
+112.6% avg upside
27 analysts
|
— | -11.7% |
|
CBIO
Crescent Biopharma
|
Jun 01, 2026 | HOLD |
Strong Buy
+26.9% avg upside
17 analysts
|
— | · |
|
SE:SOBI
Swedish Orphan Biovitrum AB
|
May 27, 2026 | BUY |
Strong Buy
-14.7% avg upside
6 analysts
|
$550.00
24.87% Upside
|
· |
|
RNAC
Cartesian Therapeutics
|
May 26, 2026 | BUY |
Strong Buy
+228.2% avg upside
19 analysts
|
$25.00
159.59% Upside
|
+38.1% |
|
EVMN
Evommune, Inc.
|
May 26, 2026 | BUY |
Strong Buy
+134.6% avg upside
12 analysts
|
$50.00
134.15% Upside
|
-14.1% |
|
IPSC
Century Therapeutics
|
May 26, 2026 | BUY |
Strong Buy
+132.5% avg upside
11 analysts
|
$5.00
118.29% Upside
|
+3.7% |
|
KRRO
Korro Bio
|
May 26, 2026 | BUY |
Strong Buy
+108.3% avg upside
19 analysts
|
$15.00
15.40% Upside
|
-10.4% |
|
MGTX
Meiragtx Holdings
|
May 26, 2026 | BUY |
Strong Buy
+130.4% avg upside
13 analysts
|
$20.00
76.60% Upside
|
-0.1% |
|
EDIT
Editas Medicine
|
May 26, 2026 | BUY |
Buy
+407.9% avg upside
33 analysts
|
$5.00
85.88% Upside
|
-14.1% |
|
BMRN
BioMarin Pharmaceutical
|
May 22, 2026 | HOLD |
Strong Buy
+72.8% avg upside
52 analysts
|
$50.00
8.61% Downside
|
+1.7% |
|
ALMS
Alumis Inc.
|
May 15, 2026 | HOLD |
Strong Buy
+63.6% avg upside
11 analysts
|
$25.00
6.70% Upside
|
+0.8% |
|
TYRA
Tyra Bioscience
|
May 14, 2026 | BUY |
Strong Buy
+57.9% avg upside
17 analysts
|
$45.00
58.96% Upside
|
-20.4% |
|
AVTX
Avalo Therapeutics
|
May 14, 2026 | BUY |
Strong Buy
+265.1% avg upside
19 analysts
|
$35.00
138.04% Upside
|
-14.0% |
|
PALI
Palisade Bio
|
May 13, 2026 | BUY |
Strong Buy
+1347.1% avg upside
15 analysts
|
$7.00
274.28% Upside
|
-5.9% |
|
CTMX
CytomX Therapeutics
|
May 11, 2026 | BUY |
Strong Buy
+269.6% avg upside
21 analysts
|
$11.00
272.90% Upside
|
-22.0% |
|
SRPT
Sarepta Therapeutics
|
May 08, 2026 | SELL |
Buy
+244.5% avg upside
49 analysts
|
$5.00
71.40% Downside
|
+21.1% |
|
GENB
Generate Biomedicines, Inc.
|
May 08, 2026 | BUY |
Strong Buy
+75.3% avg upside
6 analysts
|
$25.00
72.48% Upside
|
· |
|
CRSP
Crispr Therapeutics AG
|
May 05, 2026 | BUY |
Buy
+39.1% avg upside
41 analysts
|
$80.00
48.00% Upside
|
+3.3% |
|
LXEO
Lexeo Therapeutics, Inc.
|
Jan 13, 2026 | BUY |
Strong Buy
+313.8% avg upside
11 analysts
|
$10.00
102.76% Upside
|
-31.5% |
|
TIL
Instil Bio
|
Jan 08, 2026 | HOLD |
Buy
+343.4% avg upside
8 analysts
|
— | +3.3% |
|
BOLD
Boundless Bio Inc.
|
Oct 24, 2025 | BUY |
Buy
+529.4% avg upside
11 analysts
|
$4.00
179.67% Upside
|
-0.7% |
|
MGX
Metagenomi, Inc.
|
Oct 22, 2025 | BUY |
Strong Buy
+733.4% avg upside
7 analysts
|
$7.00
483.27% Upside
|
-55.6% |
|
ZURA
Zura Bio
|
Aug 19, 2025 | HOLD |
Strong Buy
+289.3% avg upside
12 analysts
|
$2.00
46.75% Downside
|
+103.2% |
|
GYRE
Gyre Therapeutics
|
Aug 11, 2025 | BUY |
Strong Buy
+212.0% avg upside
15 analysts
|
$25.00
299.92% Upside
|
-9.0% |
|
RLYB
Rallybio
|
Apr 30, 2025 | HOLD |
Buy
+14.8% avg upside
8 analysts
|
— | +250.8% |
|
CARM
Carisma Therapeutics
|
Apr 04, 2025 | HOLD |
Buy
+15294.7% avg upside
11 analysts
|
— | -82.3% |
|
RANI
Rani Therapeutics Holdings
|
Apr 03, 2025 | BUY |
Strong Buy
+1114.2% avg upside
10 analysts
|
$9.00
1050.28% Upside
|
-35.4% |
|
ABEO
Abeona Therapeutics
|
Mar 21, 2025 | BUY |
Strong Buy
+195.8% avg upside
17 analysts
|
$15.00
159.88% Upside
|
-13.6% |
|
OKUR
OnKure Therapeutics
|
May 14, 2024 | HOLD |
Buy
+428.3% avg upside
12 analysts
|
$15.00
234.80% Upside
|
-88.7% |
|
ADTX
Aditxt
|
Sep 06, 2023 | BUY |
Strong Buy
+609900.1% avg upside
2 analysts
|
$61.00
609900.08% Upside
|
-98.6% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.